Sign In
Buy CMPX
$2.10
+0.0200 (+0.96%)
At Close: Jun 03, 2026
Compass Therapeutics to Participate in the Leerink Partners Global Biopharma Conference
08:00am, Thursday, 29'th Feb 2024
BOSTON, Feb. 29, 2024 (GLOBE NEWSWIRE) -- Compass Therapeutics, Inc. (Nasdaq: CMPX), a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to
Compass Therapeutics, Inc. (CMPX) Upgraded to Buy: Here's What You Should Know
01:01pm, Thursday, 08'th Feb 2024
Compass Therapeutics, Inc. (CMPX) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Compass Therapeutics Provides Corporate Update
08:00am, Friday, 05'th Jan 2024
BOSTON, Jan. 05, 2024 (GLOBE NEWSWIRE) -- Compass Therapeutics, Inc. (Nasdaq: CMPX), a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to
Compass Therapeutics, Inc. (CMPX) Loses -28.57% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
11:19am, Tuesday, 14'th Nov 2023
The heavy selling pressure might have exhausted for Compass Therapeutics, Inc. (CMPX) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall
Compass Therapeutics Reports Third Quarter 2023 Financial Results and Provides Corporate Update
07:30am, Thursday, 09'th Nov 2023
BOSTON, Nov. 09, 2023 (GLOBE NEWSWIRE) -- Compass Therapeutics, Inc. (Nasdaq: CMPX), a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to
Compass Therapeutics to Participate in Upcoming Investor Events
08:00am, Wednesday, 30'th Aug 2023
BOSTON, Aug. 30, 2023 (GLOBE NEWSWIRE) -- Compass Therapeutics, Inc. (Nasdaq: CMPX), a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to
Compass Therapeutics Reports Second Quarter 2023 Financial Results and Provides Corporate Update
08:00am, Thursday, 03'rd Aug 2023
BOSTON, Aug. 03, 2023 (GLOBE NEWSWIRE) -- Compass Therapeutics, Inc. (Nasdaq: CMPX), a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to
Compass Therapeutics to Present at the Piper Sandler 34th Annual Healthcare Conference
08:00am, Tuesday, 22'nd Nov 2022
BOSTON, Nov. 22, 2022 (GLOBE NEWSWIRE) -- Compass Therapeutics, Inc. (Nasdaq: CMPX), a clinical-stage biopharmaceutical company developing proprietary antibody-based therapeutics to treat cancer, toda
Compass Therapeutics to Present at Upcoming Investment Conferences
08:00am, Tuesday, 08'th Nov 2022
BOSTON, Nov. 08, 2022 (GLOBE NEWSWIRE) -- Compass Therapeutics, Inc. (Nasdaq: CMPX), a clinical-stage biopharmaceutical company developing proprietary antibody-based therapeutics to treat cancer, toda
Compass Therapeutics to Present at the 24th Annual H.C. Wainwright Global Investment Conference
08:00am, Friday, 09'th Sep 2022
BOSTON, Sept. 09, 2022 (GLOBE NEWSWIRE) -- Compass Therapeutics, Inc. (Nasdaq: CMPX), a clinical-stage biopharmaceutical company developing proprietary antibody-based therapeutics to treat cancer, tod
Compass Therapeutics to Present at the 2022 H.C. Wainwright Annual Global Investment Conference
08:00am, Monday, 23'rd May 2022
BOSTON, May 23, 2022 (GLOBE NEWSWIRE) -- Compass Therapeutics, Inc. (Nasdaq: CMPX), a clinical-stage biopharmaceutical company developing proprietary antibody-based therapeutics to treat cancer, today
Compass Therapeutics to Host Conference Call Highlighting Clinical Data from CTX-009
04:01pm, Tuesday, 03'rd May 2022
Call scheduled for Wednesday, May 4, 2022 at 8:00 a.m. ET
Compass Therapeutics to Present at the 40th Annual J.P. Morgan Healthcare Conference
09:00am, Friday, 07'th Jan 2022
BOSTON--(BUSINESS WIRE)---- $CMPX #CMPX--Compass Therapeutics, Inc. (Nasdaq: CMPX) will present a company update at the 40th Annual J.P. Morgan Healthcare Conference on Wed., Jan. 12, 2022.
Compass Therapeutics to Present at the Piper Sandler 33rd Annual Healthcare Conference
10:00am, Monday, 22'nd Nov 2021
BOSTON--(BUSINESS WIRE)---- $CMPX #CMPX--Compass Therapeutics to Present at the Piper Sandler 33rd Annual Healthcare Conference
5 Penny Stocks To Buy Now According To Insiders In November 2021
10:15am, Friday, 19'th Nov 2021
Hot penny stocks insiders are buying in November The post 5 Penny Stocks To Buy Now According To Insiders In November 2021 appeared first on Penny Stocks to Buy, Picks, News and Information | PennySto
